The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMulberry Group Regulatory News (MUL)

Share Price Information for Mulberry Group (MUL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 110.00
Ask: 120.00
Change: 2.50 (2.22%)
Spread: 10.00 (9.091%)
Open: 112.50
High: 115.00
Low: 112.50
Prev. Close: 112.50
MUL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Mulberry Group Plc)

2 Dec 2020 18:00

RNS Number : 3431H
Frasers Group PLC
02 December 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Frasers Group Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Michael James Wallace Ashley (who controls MASH Holdings Limited which controls Frasers Group Plc)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mulberry Group Plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

02 December 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 5p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

22,121,948

36.82%

(2) Cash-settled derivatives:

 

27,489

0.04%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

22,149,137

36.86%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

N/A

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

2 December 2020

Contact name:

Thomas Piper

Telephone number:

+44 (0) 344 245 9200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEETTBRTMTTMBTM
Date   Source Headline
1st May 20247:00 amRNSYear End Trading Update
6th Feb 20249:42 amRNSDirectors Dealing
22nd Jan 20247:00 amRNSAppointment of Corporate Broker
17th Jan 20247:00 amRNSTrading Update
30th Nov 20237:00 amRNSHalf Year Results
25th Sep 20235:19 pmRNSDirectors Dealing
7th Sep 20232:11 pmRNSResult of AGM
23rd Aug 20237:00 amRNSAppointment ofl Independent Non-Executive Director
4th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
19th Jul 20237:00 amRNSGrant under 2008 Unapproved Share Option Scheme
28th Jun 20237:00 amRNSPreliminary results
22nd Jun 20237:00 amRNSAudited FY23 Results - revised announcement date
20th Apr 20237:00 amRNSYear End Trading Update
30th Nov 20229:05 amRNSSecond Price Monitoring Extn
30th Nov 20229:00 amRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf Year Results
17th Nov 20224:41 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Sep 202212:22 pmRNSAGM Statement
23rd Aug 20227:00 amRNSDirectorate Changes
3rd Aug 20229:11 amRNSAnnual Report and notice of General Meeting
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20222:08 pmRNSReplacement: Director/PDMR Shareholding
5th Jul 20225:53 pmRNSDirector/PDMR Dealing
29th Jun 20227:00 amRNSFinal Results
29th Mar 20227:00 amRNSTrading Update and notice of Full Year Results
9th Mar 20222:01 pmRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSHalf-year Report
8th Sep 20213:11 pmRNSResult of AGM
11th Aug 20215:09 pmRNSAnnual Financial Report and Notice of AGM
21st Jul 20217:00 amRNSAnnual Financial Report
6th Jul 20217:01 amRNSEarly exit of Paris lease
28th Apr 20217:00 amRNSTrading Update
20th Apr 20217:00 amRNSLaunch of New Sustainability Manifesto
17th Feb 20219:02 amRNSAward of shares to CEO
18th Dec 20207:00 amRNSStatement regarding Frasers Group plc
17th Dec 20203:42 pmRNSNo intention to bid statement: Mulberry Group plc
2nd Dec 20206:00 pmRNSForm 8 (OPD) (Mulberry Group Plc)
1st Dec 20208:44 amRNSForm 8 (OPD) – Mulberry Group plc
27th Nov 202011:45 amBUSFORM 8.5 (EPT/NON-RI) - MULBERRY GROUP PLC
26th Nov 20207:00 amRNSResults for the 26 weeks ended 26 September 2020
25th Nov 202010:42 amBUSFORM 8.5 (EPT/NON-RI) - MULBERRY GROUP PLC
23rd Nov 20209:14 amBUSFORM 8.5 (EPT/NON-RI) - MULBERRY GROUP PLC
20th Nov 202012:27 pmBUSForm 8.5 (EPT/NON-RI) - Mulberry Group plc
20th Nov 202011:38 amRNSNotification of major holdings
20th Nov 20207:00 amRNSCommencement of Offer Period
19th Nov 202012:56 pmRNSNotification of major holdings
19th Nov 20209:18 amRNSAcquisition of Shares and Dispensation from Rule 9
17th Nov 202012:43 pmRNSResult of General Meeting
13th Nov 20208:24 amRNSAppointment of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.